EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Paired genomic profiling of primary tumor and lymph-node metastases identifies candidate prognostic features in penile squamous cell carcinoma

Kexin Lou, Linghui Liang, Hongzhou Cai, Ting Xu, Fufeng Wang, Di Wang iD, Qifan Jing iD, Jiani C Yin iD, Xiaoxiang Zhang, Zicheng Xu iD

The Oncologist · 2026

DOI: 10.1093/oncolo/oyag319 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, 2026. Verfasst von Kexin Lou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Affiliated Cancer Hospital of Nanjing Medical University, N…. Hauptthemen laut MEDLINE: Penile Neoplasms, Carcinoma, Squamous Cell, Biomarkers, Tumor. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Cancer Hospital, Nanjing Municipal Science and Technology Bureau through its International/Hong Kong, Macao and Taiwan Joint Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Penile squamous cell carcinoma (PSCC) is a rare malignancy with limited genomic data in Asian populations. Lymph node metastasis heavily dictates prognosis, yet molecular determinants of progression remain poorly understood. We aimed to characterize the genomic landscape and explore candidate prognostic genomic features using paired primary and metastatic PSCC tumors. Patients and Methods Targeted next-generation sequencing (437 cancer-related genes) was performed on primary tumors and matched lymph node metastases from 20 Chinese patients. Somatic alterations, intralesional heterogeneity, and tumor mutation burden (TMB) were analyzed and correlated with disease-free survival (DFS) and overall survival (OS).

Results

The most frequent primary tumor mutations included TP53 (45%) and TERT (40%). Notably, CCND1/FGF19 co-amplification (20% of cases) was associated with inferior DFS (P = .027) and showed a trend toward shorter OS (P = .050). Conversely, T-cell receptor (TCR) pathway alterations correlated with markedly improved survival. Comparing paired lesions revealed 59.8% shared alterations. Elevated TMB in metastases relative to matched primary tumors was significantly associated with poorer DFS (P = .008), while higher intralesional heterogeneity showed a trend toward worse OS.

Conclusion

Paired profiling revealed broadly conserved genomic features together with lesion-specific divergence in PSCC. Recurrent CCND1/FGF19-containing 11q13 amplification, TCR pathway alterations, and elevated metastatic TMB warrant evaluation as potential prognostic features in larger, independently validated cohorts with integrated HPV and immune profiling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Penile NeoplasmsCarcinoma, Squamous CellBiomarkers, TumorHumansMaleLymphatic MetastasisPrognosisMiddle AgedAgedMutationGenomics

Stichwörter der Autor:innen

CCND1/FGF19 co-amplificationnext-generation sequencingpenile squamous cell carcinomaprognostic biomarkerstumor mutation burden

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.
  • Department of Urologic Surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.
  • Nanjing Geneseeq Technology Inc., Nanjing, 210000, China.
  • Department of Urologic Surgery, The Second People's Hospital of Kunshan, Kunshan, 215300, China.

ORCID-Profile: Di Wang, Qifan Jing, Jiani C Yin, Zicheng Xu

Förderung

  • Jiangsu Cancer Hospital
  • Nanjing Municipal Science and Technology Bureau through its International/Hong Kong, Macao and Taiwan Joint Research and Development Program

Zitieren

APA

Lou, K., Liang, L., Cai, H., Xu, T., Wang, F., Wang, D., Jing, Q., Yin, J. C., Zhang, X., & Xu, Z. (2026). Paired genomic profiling of primary tumor and lymph-node metastases identifies candidate prognostic features in penile squamous cell carcinoma. The Oncologist. https://doi.org/10.1093/oncolo/oyag319

Vancouver

Lou K, Liang L, Cai H, Xu T, Wang F, Wang D, et al. Paired genomic profiling of primary tumor and lymph-node metastases identifies candidate prognostic features in penile squamous cell carcinoma. The Oncologist. 2026. doi:10.1093/oncolo/oyag319

BibTeX
@article{Lou2026,
  author = {Lou, Kexin and Liang, Linghui and Cai, Hongzhou and Xu, Ting and Wang, Fufeng and Wang, Di and Jing, Qifan and Yin, Jiani C and Zhang, Xiaoxiang and Xu, Zicheng},
  title = {Paired genomic profiling of primary tumor and lymph-node metastases identifies candidate prognostic features in penile squamous cell carcinoma},
  journal = {The Oncologist},
  year = {2026},
  doi = {10.1093/oncolo/oyag319}
}
Kostenlos starten →